Benjamin F. Edwards & Company, Inc. Becton Dickinson & CO Transaction History

Benjamin F. Edwards & Company, Inc.

  • $5.69 Billion
  • Q2 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 98,720 shares of BDX stock, worth $22.1 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
98,720
Previous 96,789 2.0%
Holding current value
$22.1 Million
Previous $24 Million 3.67%
% of portfolio
0.41%
Previous 0.43%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$225.07 - $246.17 $434,610 - $475,354
1,931 Added 2.0%
98,720 $23.1 Million
Q1 2024

Apr 29, 2024
BUY
$233.45 - $247.73 $878,939 - $932,703
3,765 Added 4.05%
96,789 $24 Million
Q4 2023

Feb 06, 2024
BUY
$232.24 - $267.23 $20.9 Million - $24.1 Million
90,198 Added 3191.72%
93,024 $22.7 Million
Q3 2023

Nov 13, 2023
SELL
$254.9 - $283.59 $34,921 - $38,851
-137 Reduced 4.62%
2,826 $730,000
Q2 2023

Aug 15, 2023
BUY
$238.39 - $265.32 $71,040 - $79,065
298 Added 11.18%
2,963 $782,000
Q1 2023

Apr 27, 2023
BUY
$229.71 - $259.35 $41,118 - $46,423
179 Added 7.2%
2,665 $660,000
Q4 2022

Feb 07, 2023
SELL
$218.29 - $256.91 $27,504 - $32,370
-126 Reduced 4.82%
2,486 $632,000
Q3 2022

Oct 28, 2022
SELL
$51.03 - $264.23 $31,434 - $162,765
-616 Reduced 19.08%
2,612 $582,000
Q2 2022

Aug 12, 2022
BUY
$234.74 - $275.42 $160,796 - $188,662
685 Added 26.94%
3,228 $796,000
Q1 2022

May 04, 2022
BUY
$243.64 - $270.48 $270,927 - $300,773
1,112 Added 77.71%
2,543 $676,000
Q4 2021

Feb 07, 2022
SELL
$230.08 - $250.94 $144,030 - $157,088
-626 Reduced 30.43%
1,431 $360,000
Q3 2021

Nov 02, 2021
SELL
$232.72 - $256.47 $1.03 Million - $1.14 Million
-4,439 Reduced 68.33%
2,057 $506,000
Q2 2021

Aug 11, 2021
BUY
$232.65 - $254.58 $46,064 - $50,406
198 Added 3.14%
6,496 $1.58 Million
Q1 2021

May 14, 2021
SELL
$232.09 - $256.88 $30,171 - $33,394
-130 Reduced 2.02%
6,298 $1.53 Million
Q4 2020

Feb 16, 2021
SELL
$221.92 - $245.94 $257,649 - $285,536
-1,161 Reduced 15.3%
6,428 $1.61 Million
Q3 2020

Nov 13, 2020
SELL
$215.77 - $276.76 $52,000 - $66,699
-241 Reduced 3.08%
7,589 $1.77 Million
Q2 2020

Aug 14, 2020
SELL
$219.9 - $263.41 $89,059 - $106,681
-405 Reduced 4.92%
7,830 $1.87 Million
Q1 2020

May 07, 2020
SELL
$195.69 - $279.01 $60,076 - $85,656
-307 Reduced 3.59%
8,235 $1.89 Million
Q4 2019

Feb 06, 2020
SELL
$236.45 - $266.82 $13,477 - $15,208
-57 Reduced 0.66%
8,542 $2.32 Million
Q3 2019

Nov 05, 2019
BUY
$230.58 - $256.08 $103,530 - $114,979
449 Added 5.51%
8,599 $2.18 Million
Q2 2019

Aug 08, 2019
SELL
$217.4 - $246.08 $14,348 - $16,241
-66 Reduced 0.8%
8,150 $2.05 Million
Q1 2019

May 15, 2019
BUY
$206.05 - $248.17 $64,905 - $78,173
315 Added 3.99%
8,216 $2.05 Million
Q4 2018

Jan 31, 2019
BUY
$204.73 - $257.93 $220,494 - $277,790
1,077 Added 15.78%
7,901 $1.78 Million
Q3 2018

Oct 29, 2018
SELL
$233.07 - $256.0 $57,801 - $63,488
-248 Reduced 3.51%
6,824 $1.78 Million
Q2 2018

Jul 19, 2018
SELL
$208.1 - $233.85 $24,139 - $27,126
-116 Reduced 1.61%
7,072 $1.69 Million
Q1 2018

Apr 17, 2018
BUY
$205.46 - $240.27 $35,133 - $41,086
171 Added 2.44%
7,188 $1.56 Million
Q4 2017

Jan 17, 2018
BUY
$189.0 - $222.64 $182,385 - $214,847
965 Added 15.95%
7,017 $1.5 Million
Q3 2017

Oct 24, 2017
BUY
$186.89 - $198.9 $1.13 Million - $1.2 Million
6,052
6,052 $1.19 Million

Others Institutions Holding BDX

# of Institutions
1,738
Shares Held
250M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Benjamin F. Edwards & Company, Inc. Portfolio

Follow Benjamin F. Edwards & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email